Newsroom Search

News Media Contacts

Aleea Khan
Senior Manager, Science Communication Strategy
202-942-9365
communications@asmusa.org

Joanna Urban
Public Relations Coordinator
202-942-9365
communications@asmusa.org


SIGN UP
Subscribe to our listserv & receive press releases and other updates by email

Press Releases

Welcome to ASM's Newsroom, a resource for journalists seeking information relating to the microbiological sciences. Members of the media and the general public can access current and archived press releases highlighting the latest research published in ASM's journals or presented at our meetings.

Research presented at ASM Microbe 2017 by experts at the Fertility and Cryogenics Lab shows a reliable clinical assay that can detect the Zika virus from semen samples.

Research presented at the ASM Microbe 2017 meeting by Bryan Sanchez of California State University–Northridge in Northridge, Calif., show that antibiotic-resistant bacteria are present in many ready-to-eat foods such as fresh produce and dairy products and may serve as a source of human exposure to antibiotic-resistant bacteria.

Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence. 

A new testing and treatment approach led to shorter hospital stays for patients with Staphylococcus aureus bloodstream infections.

Bacteria in the vagina can inhibit sexually transmitted Zika virus and herpes simplex virus-2 in women, according to a new study from The University of Texas Medical Branch at Galveston.

A Lactobacillus isolate from commercial yogurt, identified as Lactobacillus parafarraginis, inhibited the growth of several multidrug-resistant/extended spectrum β-lactamase bacteria from patients at a hospital in Washington, D.C.. 

Wednesday, 24 May 2017 12:45

ASM's Spending Review

Written by

Over the past several months, the ASM leadership has been conducting a strategic spending review, driven by the necessity to achieve a 2018 breakeven budget, after several years of substantial deficits, which cannot be sustained. As part of this effort, starting in 2018, ASM will be formally discontinuing the ASM small conferences program. We have seen abstract submissions, attendance, and conference proposals trending down significantly across our portfolio, and consequently the program has been operating at a consistent loss.

The American Academy of Microbiology has released a new report on point-of-care (POC) and near-patient testing and changing diagnostic paradigms in microbiology. Technology for diagnosing infectious diseases in patients is rapidly advancing, and new diagnostic tests have the potential to meaningfully improve patient care.

Scientists have discovered a dietary strategy that may address obesity by reducing endotoxemia, a major contributor to chronic, low-grade inflammation (CLGI). The researchers uncovered an interaction between dietary capsaicin (CAP), the major pungent component in red chili, and gut microbiota. This novel mechanism for the anti-obesity effect of CAP acts through prevention of microbial dysbiosis and the subsequent gut barrier dysfunction that can lead to CLGI. The research is published May 23rd in mBio, an open access journal of the American Society for Microbiology.

A team of investigators from Agriculture and Agri-Food Canada, Guelph, Ontario, has discovered a gene that confers resistance to the important broad-spectrum antibiotic, fosfomycin. The researchers found the gene in isolates of the pathogen, Salmonella enterica, from broiler chickens. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology. 

The American Society for Microbiology has announced winners for their 3rd annual Agar Art contest

Houston Methodist Research Institute scientists used genome sequencing to discover that an otherwise rare strain of a superbug was found in more than one-third of the Houston patients studied. 

A team of researchers from the United Kingdom has developed a novel method for assessing human/pathogen interactions in the natural environment, using citizen scientists wearing boot socks over their shoes during walks in the countryside.

A study published this week in mBio demonstrates that a novel technique can be used to build better vaccines for infectious diseases. The study shows that a practical method, bacterial enzymatic combinatorial chemistry (BECC), can be used to generate functionally diverse molecules that can potentially be used as adjuvants

Three teams of researchers will be the recipients of the Kavli Microbiome Ideas Challenge that supports novel, cross-cutting tools and methods in the field of microbiome research. 

The cells of vertebrates have evolved pathways that act like an internal defense, inhibiting viral infections by preventing replication of the pathogens. Drugs that activate those existing systems suggest a promising novel approach to treating dangerous infections by Zika and other viruses, say researchers from the Vaccine and Gene Therapy Institute at Oregon Health and Science University (OHSU), in Portland.

Friday, 28 April 2017 11:28

Plague Bacteria Take Refuge In Amoebae

Written by

Yersinia pestis, the bacterium that causes bubonic plague, can survive within the ubiquitous soil protozoan, the amoeba, by producing proteins that protect against the latter microbe’s digestion.

A team of international researchers has found that a strain of anthrax-causing bacterium thought to have been viable 80 years after a thwarted World War I espionage attack, was, in reality, a much younger standard laboratory strain. The team speculates that the mix-up was due to commonplace laboratory contamination.

Colonization by the human and animal parasite, Giardia, changed the species composition of the mouse microbiome in a way that might be harmful.

Using the Pathogen Box, an open-source drug discovery project, researchers have identified a novel, highly potent antifungal agent with activity against two of the most common fungal pathogens of humans: Cryptococcus neoformans and Candida albicans.

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

50